Skip to content

Novavax Covid Vaccine Wins European Approval After Months of Delays

  • Vaccine would be first protein-based Covid shot in Europe
  • European authorization for Novavax is expected imminently
Video player cover image
Novavax CEO on Covid Vaccine Approval, Omicron Efficacy
Updated on

Novavax Inc.’s vaccine was cleared by European regulators and is set to become the first Covid-19 shot of its kind in the region, giving countries another tool as they race to protect their populations in the face of the omicron variant.

The protein-based shot, known as Nuvaxovid, was recommended by the European Medicines Agency, according to a statement Monday, and a European Commission decision authorizing the vaccine is expected imminently.